National Medical Care (4005) Fundamentals 2026 — P/E 17.1x, Revenue Analysis | SniperIQ
National Medical Care (4005) is a SA-listed Healthcare company in Medical - Care Facilities with a market capitalization of SAR 4.9B, trading at SAR 109.00 on the SAU. This SniperIQ fundamentals page covers National Medical Care's valuation (P/E 17.1x, P/B 2.5x), profitability (net margin 17.8%), revenue (SAR 1.6B in FY2025), balance-sheet quality, and AI signal context — from live market data, research only.
Full research coverage
- 8-Quarter Revenue & Margin Trend
- Debt Maturity & Coverage
- Peer Valuation Comparison
- Free Cash Flow & Owner Earnings
- AI Signal + Institutional Flow
- DCF Valuation Model
Frequently Asked Questions
What is National Medical Care's market cap?
National Medical Care (4005) has a market capitalization of approximately SAR 4.9B, trading at SAR 109.00 on the SAU. Market cap moves with the live share price.
What is National Medical Care's P/E ratio?
National Medical Care's trailing twelve-month P/E ratio is 17.1x, with a price-to-book (P/B) of 2.5x. Valuation multiples are best compared with Healthcare sector peers rather than read in isolation.
How profitable is National Medical Care?
National Medical Care runs a net profit margin of 17.8%, a gross margin of 35.5%, and an operating margin of 20.0%. Margins and ROE indicate how efficiently the business converts sales into profit and shareholder returns.
How much revenue does National Medical Care generate?
National Medical Care reported revenue of SAR 1.6B for fiscal year 2025, with net income of SAR 318M and earnings per share (EPS) of 7.13. SniperIQ tracks the full 8-quarter revenue and margin trend on the research dashboard.
Does National Medical Care pay a dividend?
National Medical Care offers a trailing dividend yield of about 2.8%. Dividend sustainability depends on payout ratio, free cash flow, and earnings stability — all tracked in SniperIQ's fundamentals view.
Is National Medical Care financially healthy?
National Medical Care carries a debt-to-equity ratio of 0.38x and a current ratio of 5.16x, with a market beta of 0.08. Lower leverage and a current ratio above 1.0 generally signal a stronger balance sheet.
Is National Medical Care a good stock to buy in 2026?
SniperIQ provides research-only market intelligence, not personalised financial advice or a buy/sell call. For National Medical Care (4005) the key facts are: market cap SAR 4.9B, P/E 17.1x, revenue SAR 1.6B, 52-week range 94.9-183.5. Weigh valuation, profitability, growth, and balance-sheet strength against Healthcare peers and form your own view.
Track National Medical Care's full fundamentals live
Get National Medical Care's 8-quarter revenue and margin trend, peer comparison, DCF model, and AI signal on the SniperIQ research dashboard.